GE Healthcare to Snag Xcellerex for Single-Use Manufacturing Technology

Xcellerex’ products have reportedly been used in more than 20 therapeutic proteins and vaccines.

Bayer HealthCare to Build $100M Testing Facility

New facility within Berkeley, CA, manufacturing site designed to support new treatments for hemophilia A.
Putting a sample into the autosampler

Chromatographic Analysis for PAT

Continuous processing means real-time monitoring process analytical technology, and enhanced chromatographic techniques—such as the IEX and SEC techniques described by Phenomenex.
MilliporeSigma’s BioContinuum™ Platform

MilliporeSigma’s BioContinuum™ Platform

Biomanufacturing professionals are enthusiastic about continuous processing because they believe it will have a significant impact on how their customers bring therapies to market, delivering them to patients faster and more cost effectively. MilliporeSigma officials...

BioMimetic Strengthens Arrangement with Novartis for Exclusive Supply of Recombinant Human Platelet-Derived Growth Factor

Firm believes that it now has a stronghold in the development of rhPDGF-BB for orthopedic indications. BioMimetic Therapeutics has amended its manufacturing and supply agreement with Novartis Vaccines and Diagnostics for the supply of bulk...
AGC Facility

AGC Triples U.S. Biopharmaceutical Production Capacity

AGC plans to install an additional twelve 2,000L single-use animal-cell bioreactors at their Seattle AGC Biologics site, as well as establish a new contract development and manufacturing facility for microbial manufacturing.
Man in lab with fermenter

Microbial Culture Systems for Bioprocessing

Microbial culture systems dominate industrial-scale production, where the large volumes rule out the possibility of employing mammalian cells. Although gigantic projects such as algae ponds engineered to literally generate tons of product lie in the future, microbial systems are currently capable of producing substantial volumes of bulk chemicals at levels competitive with conventional chemical synthetic protocols.
Funds will support development

Emergent Wins $107M Contract to Triple Anthrax Vaccine Production

Funds will support development, validation, vaccine trials, and regulatory clearance.

Genomics Departments at Yale and Erasmus Universities Adopt Caliper’s Sciclone NGS Workstation

Centers aims to automate protocols for exome-capture and library-preparation workflows.

Aldevron to Produce CureLab’s DNA Vaccine for Cancer

Aldevron was selected to produce CureLab Oncology’s DNA-based vaccine for cancer treatment.

Recently Featured

Stay Connected

Scroll Up